Citigroup, MedAssets: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Adobe Systems ( ADBE) upgraded at UBS from Neutral to Buy, UBS said. $40 price target. Survey suggests that demand is stabilizing.

Citigroup ( C) downgraded at Goldman to Buy from Neutral, Goldman Sachs said. Company also removed from the Conviction List.

Cheesecake Factory ( CAKE) upgraded at Sterne Agee from Neutral to Buy, Sterne Agee said. $36 price target. Valuation call, following the recent pullback.

CBOE Holdings ( CBOE) upgraded at Credit Suisse to Outperform from Neutral. Strong fundamentals and more deals coming, Credit Suisse said. Price target raised to $32 from $25.

Copart ( CPRT) rated new Buy at Goldman. $48 price target. Company can deliver consistent cash flow growth.

Coinstar ( CSTR) downgraded at JP Morgan from Neutral to Underweight. $42 price target. Consensus estimates appear too high.

Fifth Third ( FITB) upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $17 price target. Company has the most relative excess capital.

First Solar ( FSLR) estimates, target boosted at Goldman. Shares of FSLR now seen reaching $190, according to Goldman Sachs. Estimates also upped, given improved volume visibility. Buy rating.

First Solar ( FSLR) downgraded at UBS from Buy to Neutral, UBS said. Valuation call, based on a $180 price target.

Foster Wheeler ( FWLT) downgraded at BB&T to Hold, BB&T Capital said. Company guided toward lower near-term margins.

Goldcorp ( GG) upgraded at Deutsche to Buy, Deutsche Bank said. Company is seeing solid growth an boosted its dividend. $60 price target.

Hill-Rom ( HRC) upgraded at Soleil from Accumulate to Buy, Soleil Securities said. Valuation call, based on a $54 price target. Hospital spending appears to be improving.

InterActiveCorp ( IACI) rated new Hold at Canaccord. $28 price target. Stock is pricing in the potential for increased competition.

LDK Solar ( LDK) rated new Buy at Kaufman. $24 price target. Stock trades at a significant discount to its peers.

MedAssets ( MDAS) downgraded at Deutsche to Hold. $19 price target. Company has limited earnings visibility.

MedAssets downgraded at Piper to Underweight. $15 price target. Company is seeing lower growth across the board.

MedAssets downgraded at ThinkEquity from Buy to Hold, ThinkEquity said. $18 price target. Company slashed its forward guidance.

MedAssets downgraded at Citi from Buy to Hold on disappointing 4Q10 results, Citigroup said. Price target cut to $20 from $26.

MedAssets downgraded at Baird from Outperform to Neutral. $18 price target. Company lowered its earnings outlook.

Vail Resorts ( MTN) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $59 price target. Stock has pulled back 13% over the past two months.

Omnivision ( OVTI) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $37 price target. Company boosted forward guidance after a strong quarter.

Wells Fargo ( WFC) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. Company was also added to the Conviction List, as it consistently delivers the best business trends. $38 price target.

This article was written by a staff member of TheStreet.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says